Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Materials
/
LANXESS
LXS
LANXESS
Rising Compliance Costs And Stiff Asian Competition Will Impede Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
07 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€20.00
27.6% overvalued
intrinsic discount
16 Aug
€25.52
Loading
1Y
0.04%
7D
4.8%
Author's Valuation
€20.0
27.6% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€20.0
27.6% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-822m
8b
2014
2017
2020
2023
2025
2026
2028
Revenue €6.2b
Earnings €316.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.21%
Chemicals revenue growth rate
0.37%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.05%
Calculation
€316.04m
Earnings '28
x
6.68x
PE Ratio '28
=
€2.11b
Market Cap '28
€2.11b
Market Cap '28
/
86.35m
No. shares '28
=
€24.47
Share Price '28
€24.47
Share Price '28
Discounted to 2025 @ 7.10% p.a.
=
€19.92
Fair Value '25